194 related articles for article (PubMed ID: 29655795)
21. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat.
Wang XQ; Fan JM; Liu YO; Zhao B; Jia ZR; Zhang Q
Int J Pharm; 2011 Oct; 419(1-2):339-46. PubMed ID: 21843612
[TBL] [Abstract][Full Text] [Related]
22. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
[TBL] [Abstract][Full Text] [Related]
23. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery.
Thongborisute J; Takeuchi H; Yamamoto H; Kawashima Y
Pharmazie; 2006 Feb; 61(2):106-11. PubMed ID: 16526556
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of liposomes coated with a pH responsive polymer.
Barea MJ; Jenkins MJ; Gaber MH; Bridson RH
Int J Pharm; 2010 Dec; 402(1-2):89-94. PubMed ID: 20888403
[TBL] [Abstract][Full Text] [Related]
25. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
26. Critical role of sorafenib exposure over time for its antitumor activity in thyroid cancer.
Bellesoeur A; Carton E; Mir O; Groussin L; Blanchet B; Billemont B; Clerc J; Goldwasser F
Invest New Drugs; 2014 Jun; 32(3):569-72. PubMed ID: 24399106
[TBL] [Abstract][Full Text] [Related]
27. Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment.
Xiao Y; Liu Y; Yang S; Zhang B; Wang T; Jiang D; Zhang J; Yu D; Zhang N
Colloids Surf B Biointerfaces; 2016 May; 141():83-92. PubMed ID: 26844644
[TBL] [Abstract][Full Text] [Related]
28. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.
Oshi MA; Naeem M; Bae J; Kim J; Lee J; Hasan N; Kim W; Im E; Jung Y; Yoo JW
Carbohydr Polym; 2018 Oct; 198():434-442. PubMed ID: 30093020
[TBL] [Abstract][Full Text] [Related]
29. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
[TBL] [Abstract][Full Text] [Related]
30. Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect.
Kim GM; Kim MD; Kim do Y; Kim SH; Won JY; Park SI; Lee do Y; Shin W; Shin M
J Vasc Interv Radiol; 2016 Jul; 27(7):1086-92. PubMed ID: 27179404
[TBL] [Abstract][Full Text] [Related]
31. Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro/in vivo characterization.
Jung IW; Han HK
Int J Nanomedicine; 2014; 9():2299-306. PubMed ID: 24872692
[TBL] [Abstract][Full Text] [Related]
32. Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics.
Zheng AP; Wang JC; Lu WL; Zhang X; Zhang H; Wang XQ; Zhang Q
J Nanosci Nanotechnol; 2006; 6(9-10):2936-44. PubMed ID: 17048501
[TBL] [Abstract][Full Text] [Related]
33. Optimization, cellular uptake, and in vivo evaluation of Eudragit S100-coated bile salt-containing liposomes for oral colonic delivery of 5-aminosalicylic acid.
Alghurabi H; Jassim Muhammad H; Tagami T; Ogawa K; Ozeki T
Int J Pharm; 2023 Dec; 648():123597. PubMed ID: 37952559
[TBL] [Abstract][Full Text] [Related]
34. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
Sajeesh S; Sharma CP
Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
[TBL] [Abstract][Full Text] [Related]
35. Freeze-dried eudragit-hyaluronan multicompartment liposomes to improve the intestinal bioavailability of curcumin.
Catalan-Latorre A; Ravaghi M; Manca ML; Caddeo C; Marongiu F; Ennas G; Escribano-Ferrer E; Peris JE; Diez-Sales O; Fadda AM; Manconi M
Eur J Pharm Biopharm; 2016 Oct; 107():49-55. PubMed ID: 27349806
[TBL] [Abstract][Full Text] [Related]
36. Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor.
Choi JW; Park JH; Cho HR; Chung JW; Kim DD; Kim HC; Cho HJ
Sci Rep; 2017 Apr; 7(1):554. PubMed ID: 28373713
[TBL] [Abstract][Full Text] [Related]
37. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
38. Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.
Guo Y; Zhong T; Duan XC; Zhang S; Yao X; Yin YF; Huang D; Ren W; Zhang Q; Zhang X
Drug Deliv; 2017 Nov; 24(1):270-277. PubMed ID: 28165798
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Zhao R; Li T; Zheng G; Jiang K; Fan L; Shao J
Biomaterials; 2017 Oct; 143():1-16. PubMed ID: 28755539
[TBL] [Abstract][Full Text] [Related]
40. Encapsulation of Curcumin-Loaded Liposomes for Colonic Drug Delivery in a pH-Responsive Polymer Cluster Using a pH-Driven and Organic Solvent-Free Process.
De Leo V; Milano F; Mancini E; Comparelli R; Giotta L; Nacci A; Longobardi F; Garbetta A; Agostiano A; Catucci L
Molecules; 2018 Mar; 23(4):. PubMed ID: 29570636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]